Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature. - Wikidata - wikimedia - TriplyDB

Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.

Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.

http://www.wikidata.org/entity/Q37977994

about

Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.Update on psoriasis immunopathogenesis and targeted immunotherapy.Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events.Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases.Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells.Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells.Assessment and monitoring of biologic drug adverse events in patients with psoriasis.

P2860

Q30251926-8A2BB15D-AFF5-405B-A1E2-E75CEBDF306F Q36445919-EDDD0E3C-D4C3-49E6-B568-82EDA0BB4E6F Q38394816-86BB86C0-99D4-47B1-BBAD-C56A8221BD48 Q39004668-8A109ADF-75E6-4744-B5AF-E9EC3A4669FC Q39453926-9BCF6D21-B81D-47A7-8CBD-4FF87B443F4F Q40166499-8D8D3D9F-CEED-4AE5-8DDB-F3C249BFB3AE Q44391282-623D10A3-9495-4D60-A224-F0DBA96C4030 Q47888853-16EFBBDE-D148-4019-8C74-68B3364139CC Q48105347-285FC745-7569-4E3A-AF06-4503A92BA299 Q55153984-C0634253-704A-4CCC-8A6B-8FA506184D30

P2860

Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.

http://www.wikidata.org/entity/Q37977994

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Demyelination during tumour ne ...... and review of the literature.

@en

Demyelination during tumour ne ...... and review of the literature.

@nl

type

label

Demyelination during tumour ne ...... and review of the literature.

@en

Demyelination during tumour ne ...... and review of the literature.

@nl

prefLabel

Demyelination during tumour ne ...... and review of the literature.

@en

Demyelination during tumour ne ...... and review of the literature.

@nl

P1433

Q37977994-576C343D-5593-4BB3-ADFE-AFEA52FCA94C

P1476

Q37977994-58A044D9-D495-4497-B1E6-FCB68574C8C2

P2093

Q37977994-86D32D35-4B6C-4C62-9CB7-6DB59AF10FAA

Q37977994-9EBFF2CD-45AF-4E16-B0F0-FC73ACAD45CB

Q37977994-B7AA8586-757D-4273-89C1-8FA7EC63458B

P2860

Q37977994-1AF4A94E-D11B-4982-957D-98DE3081D702

Q37977994-1E1DCFD8-2CF3-4EBA-AA86-26E06459CBC8

Q37977994-32722DE6-8624-4034-BEC6-08542D908407

Q37977994-4FD3E995-2C63-463A-BF17-74DDAE751E68

Q37977994-514F1B6E-FFB8-48C6-8B9B-21630D7EC4FE

Q37977994-526E665D-473F-4CFA-A84E-13B9A998C83B

Q37977994-80542D91-2E57-4C5C-80BE-83F0174A470B

Q37977994-80937494-1571-4DF9-93C8-09B49C06DE50

Q37977994-812A101F-CBF9-4845-B8E6-4B05A05A7937

Q37977994-81957C27-34E4-4664-895F-281A9F5C4EE2

P304

Q37977994-94128513-C37B-49DD-8B77-FC1DA4B8265A

P31

Q37977994-5B3272DB-17D1-42C5-8DF5-CFAACD7636F8

P356

Q37977994-E520B8A6-FBCB-40E6-833A-D99340869D84

P433

Q37977994-E125156B-E103-4F01-8C76-3B26729802C7

P478

Q37977994-FE47F9F7-CCFA-484F-ABD7-1438AA6D48F9

P50

Q37977994-0CAE5317-2120-4FF8-88F1-63799238A600

Q37977994-A0666CA7-76CC-4728-A1C4-C2C172B09719

P577

Q37977994-EF2BDA9E-4EF3-422C-9750-CF50172A8AE1

P698

Q37977994-095BA8CB-36C0-48C5-A083-B15E23839A1E

P921

Q37977994-72de9854-1f0d-4395-9b7a-1fdeadb6bd1b

P356

09546634.2012.660520

P1433

Journal of Dermatological Treatment

P1476

Demyelination during tumour ne ...... t and review of the literature

@en

P2093

Charlotte Brierley

http://www.w3.org/2001/XMLSchema#string

Satveer K Mahil

http://www.w3.org/2001/XMLSchema#string

Thomasin C Andrews

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sclerosis

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Inflammatory demyelinating events following treatment with anti-tumor necrosis factor.

Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis.

Optic neuritis associated with adalimumab in the treatment of uveitis.

Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Long term safety of etanercept in elderly subjects with rheumatic diseases.

P304

38-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09546634.2012.660520

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Catherine H Smith

Jonathan N. Barker

P577

2012-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22268700

http://www.w3.org/2001/XMLSchema#string

P921